Matinas BioPharma Holdings, Inc. MTNB

Full chart Compare
Set alert

Price alert · MTNB

All alert types
1.14 USD -0.15 (-11.63%)

At closeNov 3, 2026, 5:14 PM EST

1.10 -0.04 -3.51%

After hours · Nov 3, 5:14 PM ET

1.00 Day range 1.45
0.966 52-week range 20.10
YTD
+94.54%
1 year
-14.93%

Analyst view

Price target (mean) —
Ratings (0m) 2 0 buy · 2 hold · 0 sell
  • Strong buy0
  • Buy0
  • Hold2
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 2
  • 1 month ago 2

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

MTNB analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.78-0.78 – -0.78-1.50+48.0%00.0%1
Next quarter0.000.00 – 0.00-1.500.0%00.0%0
Current year-4.06-4.06 – -4.06-5.50+26.2%0-100.0%1
Next year-3.00-4.50 – -1.50-4.06+26.1%00.0%2

Upgrades and downgrades

The latest rating changes

MTNB analyst upgrades and downgrades
DateFirmActionFromTo
Oct 31, 2024Maxim GroupDowngradeBuyHold
Jan 31, 2023HC Wainwright & Co.Reiterated—Buy
Aug 13, 2020Aegis CapitalMaintained—Buy
Jan 27, 2020Piper SandlerInitiated—Overweight
Jan 24, 2020SunTrust Robinson HumphreyInitiated—Buy
Jun 26, 2019HC Wainwright & Co.Initiated—Buy
May 17, 2019BTIGInitiated—Buy
Feb 11, 2019Roth CapitalInitiated—Buy
Nov 13, 2018Maxim GroupMaintainedBuyBuy
Aug 13, 2018Maxim GroupMaintainedBuyBuy
Jul 10, 2018Maxim GroupMaintainedBuyBuy